Literature DB >> 17371464

Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.

A A van der Klaauw1, A M Pereira, S W van Thiel, M Frolich, A Iranmanesh, J D Veldhuis, F Roelfsema, J A Romijn.   

Abstract

BACKGROUND: Radiation induces time-dependent loss of anterior pituitary function, attributed to damage of the pituitary gland and hypothalamic centres. The development of growth hormone deficiency (GHD) in irradiated acromegaly patients is not well defined.
OBJECTIVE: Detailed analysis of spontaneous 24-h GH and prolactin (PRL) secretion in relation to other pituitary functions and serum IGF-I concentrations in an attempt to find criteria for GHD in acromegalic patients with a GH response < 3 microg/l during the insulin tolerance test (ITT).
DESIGN: Plasma hormone profiles obtained by 10 min sampling for 24 h in postoperatively irradiated acromegalic patients, compared with patients cured by surgery only and matched healthy controls. SETTING/PARTICIPANTS: University setting. Fifteen subjects in each group. OUTCOME MEASURES: GH and PRL secretory parameters quantified by deconvolution, cluster, cosinor and approximate entropy (ApEn) analyses, IGF-I concentrations.
RESULTS: Irradiation attenuated pulsatile secretion of GH and PRL, but total PRL secretion was unchanged. GH and PRL secretory regularity were diminished. Circadian timing remained intact. Pulsatile GH secretion and IGF-I were correlated (R = 0.30, P = 0.04). Criteria of pulsatile GH secretion = 12 microg/l/24 h and ApEn = 0.800 separated 12 of 15 irradiated patients from all others.
CONCLUSION: Irradiated acromegaly patients with a subnormal GH response to ITT have very limited spontaneous GH secretion, with specific attenuation of the size of GH bursts and a highly irregular pattern, but with retained diurnal properties. These patients are thus likely GH-deficient and might benefit from GH replacement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371464     DOI: 10.1111/j.1365-2265.2006.02757.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

Review 1.  Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management.

Authors:  Mehdi Zeinalizadeh; Zohreh Habibi; Juan C Fernandez-Miranda; Paul A Gardner; Steven P Hodak; Sue M Challinor
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

2.  Prolactin secretion in healthy adults is determined by gender, age and body mass index.

Authors:  Ferdinand Roelfsema; Hanno Pijl; Daniel M Keenan; Johannes D Veldhuis
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

3.  Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease.

Authors:  Elisa Verrua; Emanuele Ferrante; Marcello Filopanti; Elena Malchiodi; Elisa Sala; Claudia Giavoli; Maura Arosio; Andrea Gerardo Lania; Cristina Lucia Ronchi; Giovanna Mantovani; Paolo Beck-Peccoz; Anna Spada
Journal:  Int J Endocrinol       Date:  2014-12-21       Impact factor: 3.257

4.  Twenty-four-hour growth hormone profiling in the assessment of acromegaly.

Authors:  Robert D'Arcy; C Hamish Courtney; Una Graham; Steven Hunter; David R McCance; Karen Mullan
Journal:  Endocrinol Diabetes Metab       Date:  2017-12-27

5.  Association of pre- and postoperative αKlotho levels with long-term remission after pituitary surgery for acromegaly.

Authors:  Marian Christoph Neidert; Anna Maria Zeitlberger; Henning Leske; Oliver Tschopp; Lisa Sze; Cornelia Zwimpfer; Peter Wiesli; David Bellut; René-Ludwig Bernays; Elisabeth Jane Rushing; Christoph Schmid
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.